Literature DB >> 8611682

FcR gamma-chain is essential for both surface expression and function of human Fc gamma RI (CD64) in vivo.

M J van Vugt1, I A Heijnen, P J Capel, S Y Park, C Ra, T Saito, J S Verbeek, J G van de Winkel.   

Abstract

Most Ig receptors exist as hetero-oligomeric complexes with separate ligand binding (alpha) and signal transducing (beta, gamma, or zeta) subunits. For Fc gamma RIIIa and Fc epsilon RI, association with the FcR gamma-chain is essential for surface expression. However, the human high affinity IgG receptor, hFc gamma RI, was found to be surface-expressed by itself in transient transfection models. We have now analyzed the integrity of hFc gamma RI expression in more detail in stable transfectants. In vitro we noted that, in the absence of FcR gamma-chain, surface expression of hFc gamma RI rapidly declined to background levels, in both IIA1.6 B cells and NIH3T3 fibroblasts. The effect of FcR gamma-chain on hFc gamma RI surface expression in vivo was evaluated by using two newly generated transgenic mouse lines, selectively expressing hFc gamma RI on myeloid cells. These transgenic mice were crossed with FcR gamma-chain-deficient mice. Analysis of blood monocytes and peritoneal macrophages showed that surface expression of hFc gamma RI was reduced by approximately 80%. The remaining approximately 20% of receptors were still capable of binding IgG-opsonized RBC, suggesting FcR gamma-chain not to be critical for hFc gamma RI ligand-binding capacity. Importantly, however, hFc gamma RI signaling capacity was lost in FcR gamma-chain-deficient cells. No phagocytosis could be observed using either ligand sensitized (EA-IgG2a) or CD64-targeted erythrocytes (using a bispecific antibody) in both hFc gamma RI transgenic lines. This documents the FcR gamma-chain to be indispensable for both surface membrane expression and function of human Fc gamma RI in vivo.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611682

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  33 in total

Review 1.  The Role and Function of Fcγ Receptors on Myeloid Cells.

Authors:  Stylianos Bournazos; Taia T Wang; Jeffrey V Ravetch
Journal:  Microbiol Spectr       Date:  2016-12

2.  Affinity of C-reactive protein toward FcgammaRI is strongly enhanced by the gamma-chain.

Authors:  Carlheinz Röcker; Dimitar E Manolov; Elza V Kuzmenkina; Kyrylo Tron; Holger Slatosch; Jan Torzewski; G Ulrich Nienhaus
Journal:  Am J Pathol       Date:  2007-02       Impact factor: 4.307

3.  Regulation of FcRγ function by site-specific serine phosphorylation.

Authors:  Spandan Shah; Andrew W Gibson; Chuanyi Ji; Eric Darrington; James Mobley; Kyoko Kojima; Jeffrey C Edberg; Robert P Kimberly
Journal:  J Leukoc Biol       Date:  2016-09-14       Impact factor: 4.962

4.  Interaction of two phagocytic host defense systems: Fcγ receptors and complement receptor 3.

Authors:  Zhen-Yu Huang; Sharon Hunter; Paul Chien; Moo-Kyung Kim; Tae-Hee Han-Kim; Zena K Indik; Alan D Schreiber
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

5.  FcgammaRIa-gamma-chain complexes trigger antibody-dependent cell-mediated cytotoxicity (ADCC) in CD5+ B cell/macrophage IIA1.6 cells.

Authors:  M J Van Vugt; I E Van den Herik-Oudijk; J G Van de Winkel
Journal:  Clin Exp Immunol       Date:  1998-09       Impact factor: 4.330

6.  Distinct Fcγ receptors mediate the effect of serum amyloid p on neutrophil adhesion and fibrocyte differentiation.

Authors:  Nehemiah Cox; Darrell Pilling; Richard H Gomer
Journal:  J Immunol       Date:  2014-07-14       Impact factor: 5.422

7.  Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.

Authors:  Andrew T Vaughan; Claude H T Chan; Christian Klein; Martin J Glennie; Stephen A Beers; Mark S Cragg
Journal:  J Biol Chem       Date:  2015-01-07       Impact factor: 5.157

Review 8.  Diversification of IgG effector functions.

Authors:  Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Int Immunol       Date:  2017-07-01       Impact factor: 4.823

9.  Effector function activities of a panel of mutants of a broadly neutralizing antibody against human immunodeficiency virus type 1.

Authors:  M Hezareh; A J Hessell; R C Jensen; J G van de Winkel; P W Parren
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

10.  Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.

Authors:  W Le; D Rowe; W Xie; I Ortiz; Y He; S H Appel
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.